How much evidence isn't in evidence-based guidelines?

Annals of Oncology

Volumn 27, Issue 1, 2016, Pages 205-

  Johnson, M J ^a   Currow, D C ^b  

^a UNIVERSITY OF HULL   (United Kingdom)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; OPIATE; PLACEBO;

ARTICLE; CANCER PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RELEASE; DRUG RESEARCH; DRUG RESPONSE; DRUG USE; DYSPNEA; EUROPEAN; EVIDENCE BASED PRACTICE; HEALTH SERVICE; HEART FAILURE; HUMAN; LICENSING; MALIGNANT NEOPLASTIC DISEASE; PATIENT CARE; PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEADY STATE; LUNG TUMOR; PATHOLOGY;

DYSPNEA; HUMANS; LUNG NEOPLASMS;

EID: 84959903863     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdv503     Document Type: Letter

References (7)

1. Kloke M, Cherny N; on behalf of the ESMO Guidelines Committee. Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol 2015; 26(Suppl 5): v169-v173.
2. Navigante AH, Cerchietti LC, Castro MA, Lutteral MA, Cabalar ME. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage 2006; 31: 38e47.
3. Gourley GK, Plummer JL, Cherry DA et al. A comparison of Kapanol (a new sustained-release morphine formulation), MST Continus, and morphine solution in cancer patients: pharmacokinetics aspects of morphine & morphine metabolites. In Gebhart GF, Hammond DL, Jensen TS (eds). Progress in Pain Research and Management, Vol 2. Proceedings of the 7th World Congress on Pain. Seattle, WA:IASP Press, 1994; 631-643.
4. Ekstrom M, Nilsson F, Abernathy AP, Currow DC. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc 2015; 12(7): 1079-1092.
5. Johnson MJ, Bland JM, Oxberry SG, Abernethy AP, Currow DC. Opioids for chronic refractory breathlessness: patient predictors of beneficial response. Eur Respir J 2013; 42(3): 758-766.
6. Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev 2008: CD005623.
7. Bredin M, Corner J, Krishnasamy M et al. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ 1999; 318(7188): 901-904.